Group for AIDS Research
The Group for AIDS Research (Groupe de Réflexion SIDA, GRS) organizes monthly meetings and seminars around an HIV / AIDS research topic. Meetings and seminars are open to all. Meetings are usually held on […]
THE KEY ROLE OF CXCL12/SDF1 CHEMOKINE IN THE ANGIOGENESIS/MYOGENESIS COUPLING DURING MUSCLE REGENERATION
Muscle regeneration uses specialized stem cells but it also requires coordinated action of stromal cells and supporting tissue. The study of muscle regeneration can not be only limited to the study of the activation, […]
Endocytosis: the clathrin-independent uptake of cytokine receptors
Endocytosis is an essential process used to internalize a wide range of molecules, and involved in many processes such as cell migration, cell division, immunity and pathogen invasion. Several endocytic pathways exist, enabling the […]
Viral Pathogenesis Unit’s Project
Research in the Viral Pathogenesis Unit focuses on (i) the pharmacological, biological, and physiopathological study of chemokines and chemoreceptors, with an emphasis on CXCR4 and CCR5, the two major coreceptors for HIV entry; (ii) […]
2016Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins, J. Virol. Methods 2016 Oct;236:184-95.
2016Public T cell receptors confer high-avidity CD4 responses to HIV controllers, J. Clin. Invest. 2016 Apr;.
2016TCR clonotypes: molecular determinants of T-cell efficacy against HIV, Curr Opin Virol 2016 Feb;16:77-85.
2015A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity, Retrovirology 2015;12:50.
2015SDF-1/CXCL12: A Chemokine in the Life Cycle of HIV, Front Immunol 2015;6:256.
2015[IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV], Med Sci (Paris) 2015 Jan;31(1):53-9.
2015Recognition determinants of broadly neutralizing human antibodies against dengue viruses, Nature 2015 Apr;520(7545):109-13.
2014B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis, J. Autoimmun. 2015 Jan;56:1-11.
2014The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo, Emerg Microbes Infect 2014 Sep;3(9):e62.
2014Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS 2014 Jul;28(11):1593-602.
+View full list of publications